Enrolling By InvitationNCT06034821
Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan
Medication studyAges 18–90United States + CanadaDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 90 years.
- Listed locations
- San Francisco and 9 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2023
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 1,500
- Sponsor
- Brigham and Women's Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- DEVICE, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States, Canada
- Age range
- From 18 Years to 90 Years
- Official registry ID
- NCT06034821
- Official title
Show the full official title
Rapid Reversal of Suicidal Depression: Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan (REaKT-SD)
Recruitment & locations
By invitationThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco, United States · Baltimore, United States · Belmont, United States
7 more locations
- Boston, United States
- New York, United States
- Cleveland, United States
- Pittsburgh, United States
- Houston, United States
- Salt Lake City, United States
- Toronto, Canada
Questions about this study
Who is behind this study?
The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Subanesthetic dose intravenous ketamine (KET).
Who can participate?
Listed age limits: 18 years to 90 years.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
